Xenometrix, Inc. has granted a worldwide license for gene expression profiling to Genometrix Incorporated, giving Genometrix access to claims covered in issued U.S. and European patents. The license is non-exclusive and covers the collection of gene expression profiles utilizing all platforms including microarrays. “Genometrix is a pioneer in chip-based platforms and is positioned well to Read more about Xenometrix Agrees Gene Expression Profiling Patent License To Genometrix[…]